There are big opportunities in the smaller life sciences research space. 
Growing demand for leases smaller than 10K SF, shared research space that can accommodate a multiplying number of biologics, and flexible real estate options to help startups preserve capital have put pressure on lab operators to evolve. Broadly speaking, just 15 years ago, the industry relied on three types of treatments: enzymes, protein therapeutics and monoclonal antibodies. With the advent of cell and gene therapy and mRNA technology, there are now 10 treatments — and more room to grow.
“Historically, when you change to another therapeutic modality, you actually have to completely rebuild your…
Source: Small Labs Hit Growth Spurt To Make Space For Biotech's Evolution